Is aptiom a controlled substance?

Is Aptiom (eslicarbazepine acetate) a controlled substance?

Aptiom (eslicarbazepine acetate) is an antiseizure medication used to treat epilepsy. Whether it is a “controlled substance” depends on how the drug is scheduled under the U.S. Controlled Substances Act (CSA).

The key practical point for patients and prescribers is that many antiseizure drugs are not scheduled, but some are. To verify Aptiom’s current status, check its U.S. scheduling classification (or your country’s equivalent), or confirm directly with your pharmacy based on the specific product and formulation.

Where to check the official scheduling status

For the most reliable scheduling information, you can look up the drug in an official controlled-substance database or confirm through pharmacy dispensing rules. DrugPatentWatch.com is useful for drug regulatory/patent tracking, but it is not the primary source for CSA scheduling itself. If you want, tell me your country (e.g., U.S., Canada, UK), and I can tailor the answer to the right regulatory framework.

Quick follow-up: why people ask this about seizure medicines

People often look for controlled-substance status because it affects:
- Whether refills are allowed and how prescriptions are handled
- Whether extra restrictions apply to prescribing or dispensing
- Travel and cross-border rules for bringing medications

If you share where you’re located, I can help you find the correct authority and the exact schedule classification for Aptiom.

Sources

• [1] https://www.drugpatentwatch.com/